EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Tricuspid Transcatheter Edge‐to‐Edge Repair Versus Medical Management for Tricuspid Regurgitation: A Systematic Review and Meta‐Analysis

Mangesh Kritya iD, Chloe Kharsa, Sahar Samimi iD, Gal Sella iD, Joe Aoun, Nadeen N Faza iD, Stephen H Little, Michael J Reardon iD, Marvin D Atkins, William Zoghbi, Neal S Kleiman iD, Sachin S Goel

Catheterization and Cardiovascular Interventions · 2025

DOI: 10.1002/ccd.70052 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Catheterization and Cardiovascular Interventions, 2025. Verfasst von Mangesh Kritya und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Houston Methodist DeBakey Heart & Vascular Center, Houston, Texas, USA. Hauptthemen laut MEDLINE: Cardiac Catheterization, Cardiovascular Agents, Heart Valve Prosthesis Implantation, Tricuspid Valve. Die Arbeit nennt 47 Literaturangaben. Gefördert von: The authors received no specific funding for this work..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Severe tricuspid regurgitation (TR) is associated with poor prognosis, and guideline‐directed medical therapy (GDMT) alone has limited efficacy. Transcatheter edge‐to‐edge repair (T‐TEER) has emerged as a promising therapeutic option, but its impact on clinical outcomes remains debated.

Aims

Evaluation of the efficacy and safety of T‐TEER compared to GDMT.

Methods

PubMed, EMBASE and Cochrane Central were searched for clinical trials and observational studies through February 2025, for studies comparing the clinical outcomes of T‐TEER to GDMT. The outcomes assessed were all‐cause mortality, heart failure hospitalization (HFH), cardiovascular mortality, residual TR, NYHA class improvement, stroke and new permanent pacemaker (PPM) implantation. Random‐effects models were used to calculate pooled risk ratios (RR) or hazard ratios (HR) with corresponding 95% confidence intervals (CI). Heterogeneity was assessed using the I 2 statistic. Subgroup analysis was done based on study design.

Results

Seven studies with 4220 patients were included. T‐TEER was associated with a significant reduction in mortality (HR: 0.79; 95% CI: 0.64–0.98; p = 0.03) and HFH (HR: 0.69; 95% CI: 0.53–0.91; p < 0.01) compared to GDMT. No difference was observed in cardiovascular mortality (RR: 0.96; 95% CI: 0.37–2.52) or stroke (RR: 1.06; 95% CI: 0.32–3.56). T‐TEER significantly improved TR severity (RR: 9.12; 95% CI:4.43–18.77; p < 0.001) and reduction in NYHA functional class (RR: 2.37; 95% CI: 1.15–4.88; p = 0.019), without increasing the risk of new PPM implantation (RR: 1.83; 95% CI: 0.80–4.21; p = 0.153).

Conclusion

T‐TEER is associated with improved survival, a lower risk of HFH, higher reduction in NYHA class and effective TR severity reduction without significantly increasing the risk of stroke or the need for PPM implantation. Further studies would be needed to identify optimal patient subgroup based on disease severity and clinical phenotype.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiac CatheterizationCardiovascular AgentsHeart Valve Prosthesis ImplantationTricuspid ValveTricuspid Valve InsufficiencyAgedAged, 80 and overFemaleHumansMaleMiddle AgedRecovery of FunctionRisk AssessmentRisk FactorsSeverity of Illness IndexTime FactorsTreatment Outcome

Stichwörter der Autor:innen

clinical outcomesconservative treatmentmedical managementmeta‐analysissystematic reviewtricuspid edge‐to‐edge repairtricuspid regurgitation

Substanzen

Cardiovascular Agents

Autor:innen und Institutionen

  • Department of Cardiology, Houston Methodist DeBakey Heart & Vascular Center, Houston, Texas, USA.
  • Section of Cardiology, Baylor College of Medicine, Michael E DeBakey VA Medical Center, Houston, Texas, USA.
  • Department of Cardiovascular Surgery, Houston Methodist DeBakey Heart & Vascular Center, Houston, Texas, USA.

ORCID-Profile: Mangesh Kritya, Sahar Samimi, Gal Sella, Nadeen N Faza, Michael J Reardon, Neal S Kleiman

Förderung

  • The authors received no specific funding for this work.

Zitieren

APA

Kritya, M., Kharsa, C., Samimi, S., Sella, G., Aoun, J., Faza, N. N., Little, S. H., Reardon, M. J., Atkins, M. D., Zoghbi, W., Kleiman, N. S., & Goel, S. S. (2025). Tricuspid Transcatheter Edge‐to‐Edge Repair Versus Medical Management for Tricuspid Regurgitation: A Systematic Review and Meta‐Analysis. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.70052

Vancouver

Kritya M, Kharsa C, Samimi S, Sella G, Aoun J, Faza NN, et al. Tricuspid Transcatheter Edge‐to‐Edge Repair Versus Medical Management for Tricuspid Regurgitation: A Systematic Review and Meta‐Analysis. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.70052

BibTeX
@article{Kritya2025,
  author = {Kritya, Mangesh and Kharsa, Chloe and Samimi, Sahar and Sella, Gal and Aoun, Joe and Faza, Nadeen N and Little, Stephen H and Reardon, Michael J and Atkins, Marvin D and Zoghbi, William and Kleiman, Neal S and Goel, Sachin S},
  title = {Tricuspid Transcatheter Edge‐to‐Edge Repair Versus Medical Management for Tricuspid Regurgitation: A Systematic Review and Meta‐Analysis},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2025},
  doi = {10.1002/ccd.70052}
}
Kostenlos starten →